Navigation Links
Herborium Announces Continuing Progress In Key Strategic Initiatives
Date:5/4/2012

TEANECK, N.J., May 4, 2012 /PRNewswire/ -- Herborium Group, Inc., (PINKS. HBRM) www.herborium.com, a Botanical Therapeutics® company, reports today continuing progress with its key strategic initiatives.

The company is progressing through the negotiating phase with China Health Resource Inc. regarding a potential acquisition. Both, Herborium Group and China Resource continue to work diligently towards a successful transaction.      

Herborium's partnership with KAMASUTRA (USA), LLC  to commercialize their unique vodka product containing Herborium's proprietary herbal formula  derived from the Company's sexual health formulations, has moved into the introductory marketing phase with the digital marketing plan to be initiated in June 2012.  Market share for vodka in the US is $4.8 Billion in annual sales with both on premise and home consumption on the rise.  KAMASUTRA (USA) LLC is the US partner of the German Bismarck Premium Brands GmbH  www.bismarck.de  and http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.

The market for pharmaceutical sexual health products is over $3.2 billion worldwide. The market for natural sexual health products is estimated to be over $1.5 billion, and growing.

Dr. Agnes P. Olszewski, CEO of Herborium, recently completed the National Publicity Summit in New York City (April 25-29, 2012). The Company is looking forward to multiple media exposure opportunities resulting from this Summit  that shall greatly elevate  Herborium's  public awareness.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company markets its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Group Shareholders Update
2. Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss
3. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
4. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
5. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
6. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
7. Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
8. Hill-Rom Announces Third Quarter 2012 Dividend
9. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
10. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
11. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016 In response to the opioid ... Deputy Commissioner for Medical Products and Tobacco, along with other ... the agency,s approach to opioid medications. The plan will focus ... patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 2016 , ... In the fourth quarter of 2015, document ... La Valencia Hotel in San Diego, California to discuss changes in the industry ... outstanding franchise, walking away with the coveted David Wright Award of Excellence. ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... 05, 2016 , ... Colorize is a web theme package created ... next using Colorize's dynamic moving camera. Colorize is perfect for personal and web related ... environment with 1 to 5 focus points per scene, stage floor scene presets that ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Calls Blacklist has ... completely new user interface design and the developer has fixed known bugs within the ... want to on their phone while not consuming any of their device’s battery power ...
(Date:2/4/2016)... Palos Verdes, CA (PRWEB) , ... February 04, ... ... present at the "It's All About YOU Re-Treat" on February 19-21, 2016, ... You Re-Treat" is at Rancho Palos Verdes, California. These 30 professional speakers, including ...
Breaking Medicine News(10 mins):